Archives
-
Carbapenemase Gene Transmission in CREC
2026-09-08
Chen et al. combine gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and genotyping to examine carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study shows that plasmid-associated blaNDM-1 is common and highly transferable, while strain relatedness and clinical distribution indicate simultaneous horizontal and vertical dissemination.
-
Anisomycin: JNK Agonist for Apoptosis Research
2026-09-08
Anisomycin is a JNK agonist and stress-signaling research compound used to study JNK pathway activation in apoptosis, cancer biology, and cellular stress. Product documentation identifies SKU B6674 as a 265.31 g/mol solid that is soluble in DMSO and ethanol but insoluble in water.
-
Deferiprone Workflows for Iron-Stress Research
2026-09-07
Deferiprone enables controlled iron depletion studies spanning enterocyte metabolism, tumor biology, oxidative stress, and vascular injury. This workflow-focused guide translates recent IPEC-J2 findings into practical dosing, repletion, metabolomics, and troubleshooting strategies.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-07
Learn how to use the JC-1 Mitochondrial Membrane Potential Assay Kit for ratiometric apoptosis assay design, drug screening, and mitochondrial function analysis. The workflow emphasizes CCCP controls, treatment-matched timing, and practical interpretation of mitochondrial depolarization in cancer research.
-
X-press Tag Peptide for Protein Purification
2026-09-05
X-press Tag Peptide is an N-terminal leader peptide that combines polyhistidine capture, an Xpress epitope, and an enterokinase cleavage site. Its documented 99.23% purity, ProBond compatibility, and anti-Xpress antibody detection support recombinant protein purification workflows, while the cited RHEB study provides biological context rather than direct product validation.
-
IPR-803: Urokinase Receptor Inhibitor Workflows
2026-09-04
IPR-803 is a competitive urokinase receptor inhibitor for separating uPAR–uPA signaling from general cell motility. Its use spans breast cancer invasion assays, metastasis models, and delivery-enabled pancreatic tumor-stroma research.
-
Substance P Workflows for Reproducible NK-1 Studies
2026-09-04
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with water-based preparation and clearly staged controls. A fluorescence-quality-control strategy adapted from a recent reference study adds a practical way to detect matrix interference without overstating what EEM can prove.
-
PD 173074: An Epigenetics-Aware FGFR Assay Strategy
2026-09-03
PD 173074 enables precise investigation of FGFR1 and VEGFR2 signaling, but response can depend on cellular epigenetic context. This guide translates HNSCC methylation findings into a practical, target-engagement-focused assay strategy.
-
MG-132 and TDP-43 Aggregation: Assay Logic
2026-09-03
MG-132 (Z-LLL-al) is more than an apoptosis reagent: it can expose how proteasome impairment reshapes TDP-43 aggregation and localization. This article translates the key findings of a 2023 EMBO Journal study into practical assay-design decisions for neurobiology and cancer research.
-
Brefeldin A: Reliable ER Stress Assays
2026-09-02
This scenario-driven guide explains how Brefeldin A, SKU B1400, can improve the interpretation of cell viability, proliferation, cytotoxicity, and protein-trafficking experiments. It connects dose and solvent planning with ER-stress biology, apoptosis, and practical vendor-selection criteria.
-
Aztreonam: Mechanism and Research Evidence
2026-09-02
Aztreonam is a monocyclic β-lactam antibiotic with selective activity against Gram-negative aerobic bacteria. Its research profile combines inhibition of bacterial cell wall synthesis with documented effects on bone marrow progenitor cells and liver cytochrome P450 enzymes.
-
Praeruptorin A: From Target Lists to Translation
2026-09-01
Praeruptorin A is an angular pyranocoumarin compound with a translationally relevant profile spanning iron overload, inflammation, epithelial barrier repair, metastatic behavior, and doxorubicin-associated cardiac injury. This thought-leadership guide shows how to convert those mechanisms into rigorous, decision-oriented research programs.
-
Digoxin: A Mechanism-First Research Framework
2026-09-01
Digoxin is a Na+/K+ ATPase pump inhibitor whose effects span calcium handling, contractility, and cell-specific antiviral phenotypes. This mechanism-first guide shows how to connect target perturbation with assay choice, exposure control, and translational interpretation.
-
Arrb2–6-ketoLCA Signaling in Hepatic IRI
2026-08-31
The reference study identifies hepatocyte Arrb2 as a regulator of hepatic ischemia–reperfusion injury, linking hepatocyte metabolic output to M2 macrophage polarization through 6-ketoLCA. Its combination of clinical samples, hepatocyte-focused mouse genetics, ischemia–reperfusion models, hypoxia–reoxygenation assays, and metabolomics provides a framework for studying macrophage-mediated sterile inflammation.
-
Camptothecin as a Topoisomerase I Inhibitor
2026-08-31
Camptothecin gives cancer researchers a mechanistically defined way to connect topoisomerase I trapping with DNA damage, senescence, apoptosis, and autophagy. This workflow-focused guide shows how to optimize exposure, verify pathway engagement, and extend the compound into experimental-evolution studies without confusing established evidence with forward-looking hypotheses.